Opinion: FTC’s challenge to Illumina’s vertical merger with Grail is all wrong

My mom died of stage 4 cancer in February 2008. Had the technology existed then to detect her cancer earlier, she might have met my three young daughters.

Improving cancer prevention and treatment is an urgent priority for the United States. President Biden has repeatedly signaled as much through his work with the Biden Cancer Initiative and a previous administration’s Cancer Moonshot. Yet Biden’s Federal Trade Commission is stalling a merger that would save lives while also setting a precedent against scientific innovation that could save many more.

Read the rest…

Click here to view original post